Ebola Vaccine Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Video
• Funding
• Clinical Trials
• Forums

PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response
Condition:   Ebola Virus Disease Intervention:   Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID) Recruiting - verified March 28, 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 30, 2017 Category: Research Source Type: clinical trials

African-Canadian Study of HIV-Infected Adults and a Vaccine for Ebola - ACHIV-Ebola
Condition:   Ebola Interventions:   Biological: V920 (rVSVΔG-ZEBOV-GP) Ebola Virus Vaccine;   Other: Saline Sponsors:   Dalhousie University;   Merck Sharp & Dohme Corp.;   International Development Research Centre, Canada;   Canadian Immunization Research Network Not yet recruiting - verified January 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 22, 2016 Category: Research Source Type: clinical trials